The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,098 | -36,594 | -19,585 | -64,663 | -51,481 |
| Depreciation Amortization | 12,487 | 9,592 | 6,658 | 12,092 | 8,792 |
| Income taxes - deferred | -32 | -32 | N/A | N/A | 0 |
| Accounts receivable | -12,949 | -8,969 | -985 | -5,975 | -12,142 |
| Accounts payable and accrued liabilities | 11,929 | 11,490 | 5,057 | 9,215 | 8,476 |
| Other Working Capital | -6,328 | -156 | 3,129 | 18,059 | 5,325 |
| Other Operating Activity | 20,171 | 9,479 | 738 | 4,734 | 10,306 |
| Operating Cash Flow | $-27,820 | $-15,190 | $-4,988 | $-26,538 | $-30,724 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,140 | -1,536 | -328 | -3,789 | -2,034 |
| Sale Of Investment | 0 | 0 | 0 | 50,000 | 50,000 |
| Other Investing Activity | 126 | 126 | 126 | 0 | 0 |
| Investing Cash Flow | $-2,014 | $-1,410 | $-202 | $46,211 | $47,966 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -20,028 | -20,020 | -20,010 | -39 | -29 |
| Common Stock Issued | 28,542 | 17,699 | 15,496 | 75 | 75 |
| Other Financing Activity | -691 | -456 | -226 | -3,528 | -3,374 |
| Financing Cash Flow | $7,823 | $-2,777 | $-4,740 | $-3,492 | $-3,328 |
| Beginning Cash Position | 49,669 | 49,669 | 49,669 | 33,488 | 33,488 |
| End Cash Position | 27,658 | 30,292 | 39,739 | 49,669 | 47,402 |
| Net Cash Flow | $-22,011 | $-19,377 | $-9,930 | $16,181 | $13,914 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,820 | -15,190 | -4,988 | -26,538 | -30,724 |
| Capital Expenditure | -2,140 | -1,536 | -328 | -3,789 | -2,034 |
| Free Cash Flow | -29,960 | -16,726 | -5,316 | -30,327 | -32,758 |